Business Description
Arvee Laboratories (India) Ltd
ISIN : INE006Z01016
Share Class Description:
NSE:ARVEE: Ordinary SharesCompare
Compare
Traded in other countries / regions
ARVEE.India IPO Date
2018-02-22Description
Arvee Laboratories (India) Ltd is an India based specialty chemicals company. The company products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.45 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.27 | |||||
| Interest Coverage | 3.95 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 23.13 | |||||
| Beneish M-Score | -1.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11 | |||||
| 3-Year EBITDA Growth Rate | 10.4 | |||||
| 3-Year EPS without NRI Growth Rate | 22.9 | |||||
| 3-Year FCF Growth Rate | -43.5 | |||||
| 3-Year Book Growth Rate | 14.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.51 | |||||
| 9-Day RSI | 37.37 | |||||
| 14-Day RSI | 43.82 | |||||
| 6-1 Month Momentum % | 152.01 | |||||
| 12-1 Month Momentum % | 170.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.31 | |||||
| Quick Ratio | 3.39 | |||||
| Cash Ratio | 1.64 | |||||
| Days Inventory | 79.38 | |||||
| Days Sales Outstanding | 146.55 | |||||
| Days Payable | 110.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.79 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.86 | |||||
| Operating Margin % | 2.33 | |||||
| Net Margin % | 3.34 | |||||
| FCF Margin % | 5.1 | |||||
| ROE % | 3.38 | |||||
| ROA % | 2.39 | |||||
| ROIC % | 1.15 | |||||
| ROC (Joel Greenblatt) % | 8.4 | |||||
| ROCE % | 7.09 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 228.9 | |||||
| PE Ratio without NRI | 224.2 | |||||
| Shiller PE Ratio | 119.03 | |||||
| Price-to-Owner-Earnings | 303.31 | |||||
| PS Ratio | 7.65 | |||||
| PB Ratio | 7.58 | |||||
| Price-to-Tangible-Book | 7.59 | |||||
| Price-to-Free-Cash-Flow | 150.15 | |||||
| Price-to-Operating-Cash-Flow | 74.06 | |||||
| EV-to-EBIT | 100.66 | |||||
| EV-to-EBITDA | 57 | |||||
| EV-to-Revenue | 7.43 | |||||
| EV-to-FCF | 145.67 | |||||
| Price-to-Projected-FCF | 4.11 | |||||
| Price-to-Graham-Number | 6.65 | |||||
| Price-to-Net-Current-Asset-Value | 16.18 | |||||
| Price-to-Net-Cash | 153.79 | |||||
| Earnings Yield (Greenblatt) % | 0.99 | |||||
| FCF Yield % | 0.67 | |||||
| Forward Rate of Return (Yacktman) % | 1.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arvee Laboratories (India) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 283.104 | ||
| EPS (TTM) (₹) | 0.86 | ||
| Beta | 1.33 | ||
| Volatility % | 68.04 | ||
| 14-Day RSI | 43.82 | ||
| 14-Day ATR (₹) | 13.772086 | ||
| 20-Day SMA (₹) | 228.1725 | ||
| 12-1 Month Momentum % | 170.82 | ||
| 52-Week Range (₹) | 98.1 - 315 | ||
| Shares Outstanding (Mil) | 11.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arvee Laboratories (India) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arvee Laboratories (India) Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arvee Laboratories (India) Ltd Frequently Asked Questions
What is Arvee Laboratories (India) Ltd(NSE:ARVEE)'s stock price today?
The current price of NSE:ARVEE is ₹196.85. The 52 week high of NSE:ARVEE is ₹315.00 and 52 week low is ₹98.10.
When is next earnings date of Arvee Laboratories (India) Ltd(NSE:ARVEE)?
The next earnings date of Arvee Laboratories (India) Ltd(NSE:ARVEE) is .
Does Arvee Laboratories (India) Ltd(NSE:ARVEE) pay dividends? If so, how much?
Arvee Laboratories (India) Ltd(NSE:ARVEE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers